Cresco Labs Inc. (CRLBF)
OTC
Closed
Oct 9, 2026
Day's Range
0.623152 wk Range
0.5880Overview - CRLBF - Cresco Labs Inc.
Key Statistics
Valuation
Enterprise Value
742.98M
P/E (Trailing)
‪-1.94‬
P/E (Forward)
‪-18.48‬
PEG Ratio
‪0.0097‬
Price / Sales (TTM)
‪0.42‬
Price / Book
‪0.76‬
EV / EBITDA
‪6.68‬
Profitability
Gross Margin
‪50.15%‬
Profit Margin
‪-15.49%‬
Operating Margin
‪7.70%‬
Return on Assets
‪2.99%‬
Return on Equity
‪-36.06%‬
Ownership
Shares Outstanding
371.84M
Float
345.07M
Held by Insiders
‪2.02%‬
Held by Institutions
‪3.44%‬
Price stats
Beta
‪1.76‬
50-Day Avg
‪0.7399‬
200-Day Avg
‪0.9386‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CRLBF - Cresco Labs Inc.
Peers - CRLBF - Cresco Labs Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
Profile Summary - CRLBF - Cresco Labs Inc.
About
Cresco Labs Inc. is a prominent player in the cannabis industry, focusing on the cultivation, manufacture, and distribution of cannabis products. Based in Chicago, Illinois, this vertically integrated multistate cannabis operator is committed to normalizing and professionalizing cannabis through transparency,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
